Definitive Contract 75N93023C00038
Award Date
9/1/23
Potential Completion Date
8/31/25
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Glycoscientific, L.L.C.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Athens, GA 30602, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $653,191.00 Firm Fixed Price definitive contract to Glycoscientific, L.L.C., a small business research company, to provide reagents for the study of Mycobacterium tuberculosis infections in guinea pigs. This contract supports the agency's efforts to enable research in the area of glycobiology, which focuses on the identification, characterization, and...
This is a Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Cancer Institute (NCI) to Glycoscientific, L.L.C., a small business research company. The contract is for the development of glycosylation-specific research reagents, including antibodies and aptamers, under SBIR Topic 294 Phase I. The contract has a ceiling value of $149,951 and was awarded on a firm fixed-price basis. This contract was set aside for total small business...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price definitive contract valued at $585,999.00 to Protein Innovation Labs, Inc., a small business concern, for the provision of reagents to support immunologic analysis of non-mammalian models. This contract was awarded under the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) Small Business Innovation...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Government Scientific Source Inc., a for-profit organization. The $57,081.35 contract is for the provision of reagents and laboratory equipment supplies, and does not have a set-aside designation. Government Scientific Source Inc. is an experienced federal contractor, holding various prime contract awards and subcontracts with agencies like the...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $56,317.84 firm fixed price delivery order contract to Government Scientific Source Inc., doing business as G S S, for standard biotools reagent kits. The contract was awarded utilizing G S S's Multiple Award Schedule contract vehicle, which provides access to a wide range of laboratory supplies and equipment. The reagent kits will support NIH research efforts...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $15,800 firm fixed price purchase order to Government Scientific Source Inc. to provide reagents for the Vaccine Research Center. The contract has no set-aside designation and deliveries are to be completed by December 31, 2023 at the place of performance in Herndon, Virginia. Government Scientific Source Inc. will supply the reagents requested under the...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, awarded a firm fixed-price purchase order to Government Scientific Source Inc., a for-profit organization, for the procurement of 10X Genomics Visium HD and Dual Index reagents. The $128,251.03 contract is to support ongoing NIAID research related to tick-borne diseases that began before January 20, 2025. The contract is not set aside for small businesses. The reagents are critical for...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract valued at $52,112.47 to Government Scientific Source Inc. for the procurement of 10X Genomics single-cell reagents and kits. This order is part of ongoing research efforts and will provide the necessary supplies, including GEM-X Universal Gene Expression kits, Chromium Single Cell Chip Kits, Dual Index Kits, and Library Construction Kits, to support NIAID's genomic research...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc. for 10X Genomics assays and reagents. The $52,949.00 contract is for Xenium Prime 5K reagents, including a custom gene panel and five assay kits, to support ongoing immunological research projects at the NIAID Laboratory of Immunology (LISB). Specifically, the Schwartzberg Lab will use the...